title: Study on the Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma: Not a Case-Control Study.
authors.affiliation: Melanoma Unit, Dermatology Department, Hospital Clínic, Universidad de Barcelona, Barcelona, Spain2Institut d'investigacions biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
authors.forename: Susana
authors.initials: S
authors.lastname: Puig
authors.affiliation: Clinical Epidemiology Unit, Istituto Dermopatico dell'Immacolata-IRCCS, Rome, Italy.
authors.forename: Francesca
authors.initials: F
authors.lastname: Sampogna
authors.affiliation: Dermatology Department, Instituto Dermatológico GlobalDerm, Córdoba, Spain.
authors.forename: Antonio
authors.initials: A
authors.lastname: Tejera-Vaquerizo
mesh_terms: D000813:Anilides; D002280:Basal Cell Carcinoma; D002294:Carcinoma, Squamous Cell; D016022:Case-Control Studies; D006801:Humans; D011725:Pyridines; D012878:Skin Neoplasms
chemical_list: D000813:Anilides; C538724:HhAntag691; D011725:Pyridines